"At GenesisCare, we offer multidisciplinary personalised cancer treatments based on the needs of our patients as individuals. Our focus is on building relationships with humans that get us talked about long after treatment ends. We're an organisation with a local, national and global presence, providing care where it's needed. Our radiation and medical oncologists are among the world's leading specialists in the treatment of cancer. We invest in innovative treatments, advanced technologies and clinical trials with the goal to continually improve patient outcomes. Our services include radiation oncology, medical oncology and theranostics."

During the past decade, Genesis Care North Shore conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesis Care North Shore" #1 sponsor was "Amgen" with 3 trials, followed by "University of Sydney" with 2 trials sponsored, "Akeso" with 1 trials sponsored, "Amplia Therapeutics Limited" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Care North Shore" #1 collaborator was "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer Australia" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Care North Shore" are "Advanced Solid Tumors" (1 trials), "Bladder Cancer" (1 trials), "Colorectal Cancer (CRC)" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "Genesis Care North Shore" in a lesser frequency.

Most popular intervention types in "Genesis Care North Shore" are "Drug" (8 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sotorasib" (2 trials), "AMG 404" (1 trials), "AMP945 RP2D" (1 trials), "AMP945 ascending doses" (1 trials) and "BI 1701963" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Care North Shore" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Genesis Care North Shore". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Genesis Care North Shore, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Care North Shore, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".